Immuno-Oncology Clinical Trials Market By Therapy Type (Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Therapy (ACT), Monoclonal Antibodies, Oncolytic Virus Therapy, Cytokine-Based Therapy, Others), By Trial Phase (Phase I, Phase II, Phase III, Phase IV), By Cancer Type (Hematologic Malignancies {Leukemia, Lymphoma, Multiple Myeloma}, Solid Tumors {Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Pancreatic Cancer, Head & Neck Cancer, Others}), By Design Type (Interventional Trials, Observational Studies, Expanded Access Studies), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Contract Research Organizations (CROs), Government & Non-Profit Organizations), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles and Market Forecast, 2025 – 2035

Published Date: Mar 2025 | Report ID: MI2209 | 210 Pages


Report Coverage:

By Therapy Type

  • Checkpoint Inhibitors
  • Cancer Vaccines
  • Adoptive Cell Therapy (ACT)
  • Monoclonal Antibodies
  • Oncolytic Virus Therapy
  • Cytokine-Based Therapy
  • Others

By Trial Phase

  • Phase I 
  • Phase II 
  • Phase III 
  • Phase IV

By Cancer Type

  • Hematologic Malignancies
    • Leukemia
    • Lymphoma
    • Multiple Myeloma
  • Solid Tumors
    • Lung Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Prostate Cancer
    • Melanoma
    • Ovarian Cancer
    • Pancreatic Cancer
    • Head & Neck Cancer
    • Others

By Design Type

  • Interventional Trials
  • Observational Studies
  • Expanded Access Studies

By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutions
  • Contract Research Organizations (CROs)
  • Government & Non-Profit Organizations

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

List of Companies:

  • Merck & Co., Inc.
  • Bristol-Myers Squibb Company
  • Genentech, Inc.
  • AstraZeneca plc
  • Pfizer Inc.
  • Novartis AG
  • Gilead Sciences, Inc.
  • Johnson & Johnson
  • Amgen Inc.
  • Moderna, Inc.
  • Eli Lilly and Company
  • Sanofi S.A.
  • GlaxoSmithKline plc (GSK)
  • Regeneron Pharmaceuticals, Inc.
  • BeiGene, Ltd.

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.